Core Viewpoint - The company is actively involved in the establishment of a private equity fund focused on the biopharmaceutical industry, aiming to promote industry integration and transformation [1] Group 1 - The company has participated as a limited partner in the Shanghai Biopharmaceutical M&A Private Equity Fund, which serves as a significant tool for enhancing the biopharmaceutical industry chain [1] - The fund aims to facilitate mergers and acquisitions, thereby supporting the growth and strengthening of "chain master" enterprises [1] - The company's efforts are directed towards promoting high-quality development through various initiatives [1]